Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 595 of 6351
-
New hope for pancreatic cancer: targeted pill studied in nationwide telemedicine trial
Disease control Recruiting nowThis phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or has spread from where it first started to othe…
Phase 2 • Sponsor: Sameek Roychowdhury • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Placental patch could speed healing of stubborn diabetic foot sores
Disease control Recruiting nowA multicenter, prospective, controlled clinical trial evaluating the efficacy of a single layer placental-based allograft and standard of care in the management of nonhealing diabetic foot ulcers.
Phase 4 • Sponsor: Applied Biologics, LLC • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New hope against deadly mold infections enters final testing
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of fosmanogepix (administered IV or oral) for the treatment of adult patients with invasive mold infections. The study is looking for patients who have been diagnosed with invasive mold infections. The maximum study…
Phase 3 • Sponsor: Basilea Pharmaceutica • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New Antibody-Drug conjugate takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetic, pharmacodynamic, preliminary anti-tumor activity, and to determine the recommended Phase II dose (RP2D) of the ALE.P03 monotherapy in adult patients with selected squamous solid tumors.
Phase 1/2 • Sponsor: Alentis Therapeutics AG • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Non-Invasive probe spots tough nasal polyps in seconds
Diagnosis Recruiting nowChronic rhinosinusitis with nasal polyps (CRSwNP) is a common condition causing nasal congestion, discharge, and reduced sense of smell, seriously affecting patients' quality of life. A subtype called eosinophilic CRSwNP (eCRSwNP) is difficult to treat and often recurs after surg…
Sponsor: The Affiliated Hospital of Qingdao University • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Could an MS pill protect the brain in Alzheimer's? new trial launches
Disease control Recruiting nowCollaboration with multiple sclerosis (MS) specialty colleagues led us to formulate the central hypothesis that Siponimod could lower the rate of brain atrophy in Alzheimer's disease (AD) subjects. To test our central hypothesis, we will carry out an 18-month Phase II, double-bli…
Phase 2 • Sponsor: St. Joseph's Hospital and Medical Center, Phoenix • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New hope for hard-to-treat breast cancer: targeted combo enters late-stage trial
Disease control Recruiting nowThis is a global, multicenter, open-label, randomized Phase 3 study comparing the efficacy and safety of RLY-2608 (zovegalisib) + fulvestrant to capivasertib + fulvestrant for the treatment of patients with HR+/HER2- ABC with PIK3CA mutation following recurrence or progression on…
Phase 3 • Sponsor: Relay Therapeutics, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New combo may boost CAR-T success in tough lymphoma
Disease control Recruiting nowThe purpose of this clinical trial is to learn if the study treatment Loncastuximab tesirine and Rituximab is safe and efficient before standard of care chimeric antigen receptor T-cell (CAR-T) therapy in patients with relapsed or refractory large B-cell lymphoma.
Phase 2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New shot could help kids with kidney disease avoid steroids
Disease control Recruiting nowThis is an open - label study to evaluate the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of SG301 Subcutaneous injection in children with frequently relapsing or steroid - dependent nephrotic syndrome.
Phase 2 • Sponsor: Mao Jianhua • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Heart showdown: stenting may rival bypass surgery in emergency patients
Disease control Recruiting nowMILESTONE STUDY is dedicated to problems connected with patients with multivessel coronary artery disease and/or with left main narrowing who present symptoms of acute ischemia. For such kind of patients according to current ACC/AHA guidelines CABG (surgical revascularization) is…
Sponsor: American Heart of Poland • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New mRNA flu shots show promise in large adult trial
Vaccine Completed"The purpose of this study is to assess the reactogenicity, safety and immune response of GlaxoSmithKlines (GSK) messenger RNA (mRNA)-based multivalent seasonal influenza vaccine candidates administered in healthy younger and older adults."
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Vaccine
Last updated Jun 27, 2026 12:38 UTC
-
New scope procedure may replace surgery for early colon cancer
Disease control Recruiting nowThe trial is a randomized head-to-head comparison of the benefits, harms and burdens of endoscopic full-thickness resection (eFTR), a novel, minimally invasive endoscopic treatment modality, for early colon cancer as compared to standard-of-care surgery.
Phase 3 • Sponsor: Norwegian Department of Health and Social Affairs • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New cocktail of drugs takes on pancreatic cancer
Disease control Recruiting nowTo evaluate the safety and efficacy of HRS-4642 in Combination With AG and Adebrelimab for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer
Phase 2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New hope for lupus patients with lung scarring: telitacicept trial launches
Disease control Recruiting nowRecent data indicate that Telitacicept is beneficial for lupus nephritis. Our goal is to determine whether Telitacicept is an effective and safe treatment, compared to standard-of-care Cyclophosphamide, for subclinical and clinical ILD in patients with early lupus.
Phase 4 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Custom mRNA vaccine aims to stop Cancer's return after surgery
Vaccine Recruiting nowThe goal of this interventional clinical study is to learn the safety and preliminary efficacy of XH001 injection (Personalized mRNA tumor neoantigen vaccine) combined with standard adjuvant treatment in treating patients with high-risk recurrent solid tumors after radical surger…
Phase 1 • Sponsor: Shenzhen Xinhe Biomedical • Aim: Vaccine
Last updated Jun 27, 2026 12:35 UTC
-
Can a Blood-Derived injection strengthen pelvic floor repair?
Disease control CompletedPelvic organ prolapse (POP) is a common pelvic floor disorder associated with impaired quality of life and considerable postoperative recurrence following native tissue repair. Platelet-rich plasma (PRP) has emerged as a regenerative adjunct to improve tissue healing and surgical…
Sponsor: Andalas University • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a biological graft improve dialysis access?
Disease control Recruiting nowThe study is planned to be conducted at multiple centers, with an intended enrollment of 326 subjects. Protocol-eligible subjects will be randomized in a 1:1 ratio to either the investigational group or the control group. The investigational group will receive a Biological Vascul…
Sponsor: Longhua Hospital • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New cocktail of drugs and procedure aims to stop liver cancer in its tracks
Disease control Not yet recruitingTo evaluate the efficacy of Iparomlimab and Tuvonralimab in combination with Lenvatinib and TACE for advanced hepatocellular carcinoma by assessing Progression-Free Survival (PFS).
Phase 2 • Sponsor: The Second Affiliated Hospital of Shandong First Medical University • Aim: Disease control
Last updated Jun 26, 2026 13:21 UTC
-
AI eye on the heart: new tool could catch silent attacks
Diagnosis Recruiting nowThe goal of this clinical trial is to evaluate whether an artificial intelligence (AI)-based ECG interpretation tool improves the early diagnosis and treatment of occlusion myocardial infarction (OMI) in adults presenting with suspected acute coronary syndrome (ACS) who do not me…
Sponsor: Cardiocentro Ticino • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
Can a weekly shot help people shed weight without diabetes?
Disease control CompletedThis study is a multicenter, randomized, double-blind, placebo-controlled phase II study conducted in China. It aims to evaluate the efficacy and safety of MWN109 injection in non-diabetic participants with overweight or obesity. A total of 120 participants were enrolled in the …
Phase 2 • Sponsor: Shanghai Minwei Biotechnology Co., Ltd • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC